cyclosporine has been researched along with Rhabdomyosarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athar, M; Elmets, CA; Heilpern, C; Kopelovich, L; Li, C; Pressey, JG; Timares, L; Weng, Z; Xu, H; Xu, J | 1 |
| Casadio, F; Corti, B; Croci, S; D'Errico Grigioni, A; Grigioni, WF; Landuzzi, L; Lollini, PL | 1 |
| Chan, HS; Doyle, J; Greenberg, ML; Koren, G; Liau-Chu, M; Theis, JG | 1 |
| Cowie, FJ; Pinkerton, CR; Pritchard-Jones, K; Renshaw, J | 1 |
1 trial(s) available for cyclosporine and Rhabdomyosarcoma
| Article | Year |
|---|---|
Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL.
Topics: Adolescent; Anaphylaxis; Antineoplastic Combined Chemotherapy Protocols; Azo Compounds; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Ethanol; Glycerol; Humans; Immunosuppressive Agents; Infusions, Intravenous; Pharmaceutical Vehicles; Premedication; Rhabdomyosarcoma; Solubility; Solvents; Statistics, Nonparametric | 1995 |
3 other study(ies) available for cyclosporine and Rhabdomyosarcoma
| Article | Year |
|---|---|
Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.
Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Cyclosporine; Cytochromes c; Drug Interactions; Female; G1 Phase; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mutation; Pyrimidines; Reactive Oxygen Species; Rhabdomyosarcoma; SOX9 Transcription Factor; Transcriptional Activation; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2010 |
Toward the definition of immunosuppressive regimens with antitumor activity.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Jurkat Cells; Leflunomide; Liver Neoplasms; Mycophenolic Acid; Rhabdomyosarcoma; Sirolimus | 2005 |
Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Survival; Cisplatin; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Lung Neoplasms; Methotrexate; Neuroblastoma; Rhabdomyosarcoma; Time Factors; Tumor Cells, Cultured; Verapamil; Vincristine | 1998 |